CorMedix Inc. (NASDAQ: CRMD) started the day on April 14, 2021, with a price decrease of -15.37% at $7.93. During the day, the stock rose to $9.46 and sunk to $7.851 before settling in for the price of $9.37 at the close. Taking a more long-term approach, CRMD posted a 52-week range of $3.47-$18.80.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 2.60%. Meanwhile, its Annual Earning per share during the time was 23.30%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 57.20%. This publicly-traded company’s shares outstanding now amounts to $32.42 million, simultaneously with a float of $31.48 million. The organization now has a market capitalization sitting at $311.01 million. At the time of writing, stock’s 50-day Moving Average stood at $11.12, while the 200-day Moving Average is $7.48.
If we measure the efficiency of the company that is accounted for 35 employees. It has generated 6,835 per worker during the last fiscal year. Meanwhile, its income per employee was -629,362. The stock had 141.06 Receivables turnover and 0.01 Total Asset turnover. For the Profitability, stocks gross margin was -45.61, operating margin was -11378.44 and Pretax Margin of -11368.54.
CorMedix Inc. (CRMD) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. CorMedix Inc.’s current insider ownership accounts for 1.20%, in contrast to 24.60% institutional ownership. According to the most recent insider trade that took place on Sep 04, this organization’s Director bought 5,715 shares at the rate of 3.99, making the entire transaction reach 22,816 in total value, affecting insider ownership by 60,498. Preceding that transaction, on Sep 03, Company’s Chief Financial Officer bought 1,150 for 4.07, making the whole transaction’s value amount to 4,680. This particular insider is now the holder of 1,150 in total.
CorMedix Inc. (CRMD) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 12/30/2020, the organization reported -$0.19 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at -$0.22) by $0.03. This company achieved a net margin of -9207.70 while generating a return on equity of -64.91. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
CorMedix Inc.’s EPS increase for this current 12-month fiscal period is 57.20% and is forecasted to reach -0.43 in the upcoming year.
CorMedix Inc. (NASDAQ: CRMD) Trading Performance Indicators
Let’s observe the current performance indicators for CorMedix Inc. (CRMD). It’s Quick Ratio in the last reported quarter now stands at 11.50. The Stock has managed to achieve an average true range (ATR) of 0.81. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1555.07.
In the same vein, CRMD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.77, a figure that is expected to reach -0.18 in the next quarter, and analysts are predicting that it will be -0.43 at the market close of one year from today.
Technical Analysis of CorMedix Inc. (CRMD)
If we take a close look at the recent performances of CorMedix Inc. (NASDAQ: CRMD), its last 5-days Average volume was 0.62 million that shows plunge from its year to date volume of 1.22 million. During the previous 9 days, stock’s Stochastic %D was recorded 28.05% While, its Average True Range was 0.84.
Raw Stochastic average of CorMedix Inc. (CRMD) in the period of the previous 100 days is set at 12.55%, which indicates a major rise in contrast to 3.10% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 97.07% that was lower than 133.03% volatility it exhibited in the past 100-days period.